Praxis Precision Medicines Stock Analysis
| PRAX Stock | USD 54.76 0.47 0.87% |
Praxis Precision Medicines is undervalued with Real Value of 63.22 and Hype Value of 54.71. The main objective of Praxis Precision stock analysis is to determine its intrinsic value, which is an estimate of what Praxis Precision Medicines is worth, separate from its market price. There are two main types of Praxis Precision's stock analysis: fundamental analysis and technical analysis.
The Praxis Precision stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Praxis Precision is usually not traded on Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday. Praxis Stock trading window is adjusted to America/New York timezone.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Praxis Precision Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Praxis Stock Analysis Notes
About 100.0% of the company shares are owned by institutional investors. The book value of Praxis Precision was at this time reported as 19.21. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Praxis Precision Med recorded a loss per share of 12.4. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 29th of November 2023. Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people. To find out more about Praxis Precision Medicines contact Marcio MBA at 617 300 8460 or learn more at https://praxismedicines.com.Praxis Precision Med Investment Alerts
| Praxis Precision Med had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 8.55 M. Net Loss for the year was (182.82 M) with loss before overhead, payroll, taxes, and interest of (214.22 M). | |
| Praxis Precision Medicines currently holds about 165.4 M in cash with (131.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
| Praxis Precision Med has a frail financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are owned by institutional investors |
Praxis Precision Med Upcoming and Recent Events
Earnings reports are used by Praxis Precision to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Praxis Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.14 B.Technical Drivers
As of the 10th of October, Praxis Precision holds the Risk Adjusted Performance of 0.0251, coefficient of variation of 3514.14, and Semi Deviation of 4.11. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Praxis Precision, as well as the relationship between them.Praxis Precision Med Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Praxis Precision Med more heavily than older values.
Praxis Precision Med Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Praxis Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Praxis Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Praxis Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Praxis Precision Outstanding Bonds
Praxis Precision issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Praxis Precision Med uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Praxis bonds can be classified according to their maturity, which is the date when Praxis Precision Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PRAXAIR INC 355 Corp BondUS74005PBD50 | View | |
| US74005PBT03 Corp BondUS74005PBT03 | View | |
| PRAXAIR INC 32 Corp BondUS74005PBQ63 | View | |
| US74005PBS20 Corp BondUS74005PBS20 | View |
Praxis Precision Predictive Daily Indicators
Praxis Precision intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Praxis Precision stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Praxis Precision Forecast Models
Praxis Precision's time-series forecasting models are one of many Praxis Precision's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Praxis Precision's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Praxis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Praxis Precision prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Praxis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Praxis Precision. By using and applying Praxis Stock analysis, traders can create a robust methodology for identifying Praxis entry and exit points for their positions.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Praxis Precision to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.